权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

A Comprehensive Model to Assess the Cost-Effectiveness of Patient Navigation

评估患者导航成本效益的综合模型

基本信息

批准号：
8300383
负责人：
Lovell Allan Jones
金额：
$ 33.79万
依托单位：
UNIVERSITY OF CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-09-30 至 2012-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8300383
关键词：
Comprehensive Model Assess Cost Effectiveness

项目摘要

DESCRIPTION (provided by applicant): Patient navigation (PN) is a community-centered approach that can potentially reduce health disparities by enhancing access to care at an earlier stage of the disease continuum for underserved populations, such as racial/ethnic minorities or individuals with low socioeconomic status. To date there are two large-scale federally-funded programs that involve PN interventions; one is the patient navigation research program sponsored by the National Cancer Institute (NCI); the other is a series of demonstration projects supported by Centers for Medicare and Medicaid Services (CMS). The NCI-sponsored sites mostly initiate PN services at the time an abnormal screening result is detected, whereas the CMS- sponsored sites attempt to engage PN services at an earlier stage so as to increase the uptake of cancer screening. Little is known about the cost-effectiveness of PN compared to usual care (UC) for either type of PN services. The objective of the proposed study is to develop a comprehensive research framework to assess the cost-effectiveness of a PN program targeted at various points in the continuum of cancer care - screening, diagnosis, and treatment. The study has three specific aims: (1) to evaluate the cost-effectiveness between usual care and patient navigation started at the time that an abnormal screening result was detected; (2) to compare the cost-effectiveness between usual care and patient navigation targeted at improving the uptake of cancer screening; and (3) to assess the cost-effectiveness between patient navigation programs initiated at various time points of the cancer care continuum. The study will utilize databases developed from the CMS demonstration site at University of Texas M.D. Anderson Cancer Center, supplemented with Medicare claims and information obtained from the literature, to evaluate the short-term and long-term cost-effectiveness of PN versus UC. Study perspective will include that of society, payors, and health care providers that employ patient navigators to facilitate services for their patients or the at-risk population in the surrounding neighborhood. We will employ appropriate statistical methods of cost-effectiveness analyses using patient-level data in the short-term analysis and will develop cancer-specific Markov models to assess the long-term cost-effectiveness. Findings from the proposed study will inform policy makers on the costs, comparative effectiveness, and cost-effectiveness of PN versus UC initiated at various time points of the cancer care continuum, as well as the comparison between PN services started at different time points. In addition, a user-friendly model will be developed for the study of the cost- effectiveness of PN; the model will be available to other intervention sites of PN services upon request. Patient navigation is a community-centered approach that can potentially reduce health disparities by enhancing access to care at an earlier disease stage for underserved populations. This study will develop a comprehensive and user-friendly model to compare the cost-effectiveness of patient navigation and usual care for navigation services initiated at different time points of the cancer care continuum. We will address both short-term and long- term cost-effectiveness PN services from three different interest groups: societal as a whole, insurance payors, and health care providers.

描述（由申请人提供）：

项目成果

期刊论文数量（4）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Cost-Effectiveness Analysis of a Capitated Patient Navigation Program for Medicare Beneficiaries with Lung Cancer.

针对肺癌医疗保险受益人的按人头付费患者导航计划的成本效益分析。

DOI：
10.1111/1475-6773.12333
发表时间：
2016
期刊：
Health services research
影响因子：
3.4
作者：
Shih,Ya-ChenTina;Chien,Chun-Ru;Moguel,Rocio;Hernandez,Mike;Hajek,RichardA;Jones,LovellA
通讯作者：
Jones,LovellA

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC).